Rocket Pharmaceuticals, Inc. RCKT
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Richard Law | Goldman Sachs | 2.48 $ | 2 $ | -0.48 % | 28/05/2025 |
| Andrew Tsai | Jefferies | 2.475 $ | 2.5 $ | 0.02 % | 28/05/2025 |
| Yun Zhong | Wedbush | 12.03 $ | 32 $ | 19.97 % | 30/12/2024 |
| Whitney Ijem | Canaccord Genuity | 17.09 $ | 39 $ | 21.91 % | 11/11/2024 |
| Whitney Ijem | Canaccord Genuity | 21.8 $ | 38 $ | 16.20 % | 18/09/2024 |
| Michael E Ulz | Morgan Stanley | 21.18 $ | 45 $ | 23.82 % | 17/09/2024 |
| Richard Law | Goldman Sachs | 26.72 $ | 39 $ | 12.28 % | 02/04/2024 |
| Esther Rajavelu | UBS | 30.8 $ | 69 $ | 38.20 % | 12/08/2021 |